Robocath’s R-One+ Robotic Platform Launched for PCI Procedures

May 16, 2023—Robocath, a Rouen, France–based company that designs, develops, and commercializes robotic solutions for the treatment of cardiovascular diseases, announced the launch of its R-One+ robotic platform.

According to the Robocath, the R-One+ robotic solution allows the interventional cardiologist to perform coronary angioplasties by controlling devices using an integrated control command unit located in the cath lab or control room, thereby protecting against radiation-induced injuries and making the percutaneous coronary intervention (PCI) procedure easier and safer. The company added that with R-One+, operators can perform enhanced hand gestures with greater precision and in more comfortable working conditions.

Mohammed Nejjari, MD, interventional cardiologist at the Centre Cardiologique du Nord in Saint-Denis, France, commented in Robocath’s press release, “For the first time, I was able to perform several robotic angioplasties from the comfort of my chair in the control room, where I was completely shielded from x-rays and could dispense with my lead apron. I also benefited from the excellent visibility on the radioscopy and hemodynamic monitoring screens.”

Dr. Nejjari continued, “This new setup has changed the way we organize our procedures and has given nursing staff the opportunity to develop new skills. This new approach has also enabled doctors to shift their focus back to their core activities and to perform procedures in complete safety and with millimeter precision. I’m excited to incorporate this new robotic technology into my day-to-day work. Without doubt, it opens up some new and extremely promising avenues for the treatment of cardiovascular diseases, especially in the case of long and complex procedures.”

Also in the company’s press release, Professor Michael Haude, MD, interventional cardiologist at Lukaskrankenhaus in Neuss, Germany, stated, “R-One+ makes it extremely easy to position devices with millimeter precision. It’s also much more comfortable to operate using robotic technology, and, as the principal operator, I am completely protected from radiation. I firmly believe that robotics has a major role to play in the transformation of interventional cardiology, and the use of this technology will mark a new chapter in the history of our field.”

Robocath advised that it is showcasing R-One+ at the EuroPCR course held May 16-19 in Paris, France, at the company’s booth. It was also presented in a dedicated session: “Robotic PCI: real-life experience with a new robotic platform,” led by Jean Fajadet, MD, and Professor Stefan Verheye, MD, and including two case studies from Prof. Haude and Dr. Nejjari.